Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OSCR · against 151 other Healthcare companies of similar size
Ranked #13 of 152 · scores higher than 91% of peers
Bars: peers in each 10-point band of the growth score19 peers with a growth score of 90–100, including OSCR · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | OSCR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 152 reported | 42.8% | 10.2% | 87% | 33% | |
| Earnings per share growthHigher is better · 111 reported | Not reported | 14.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 147 reported | 45.6% | 10.9% | 91% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 7.3B USD | 97 | 74 | |
| 5 | 16.5B USD | 96 | 37 | |
| 9 | 10.5B USD | 94 | 56 | |
| 11 | 9.4B USD | 93 | 70 | |
| 11 | 9.2B USD | 93 | 39 | |
| 13 | 7.3B USD | 92 | 32 | |
| 13 | 10.0B USD | 92 | 64 | |
| 15 | 138.4B HKD (≈$17.7B) | 91 | 70 | |
| 15 | 6.0B USD | 91 | 32 | |
| 17 | 6.3B USD | 90 | 78 | |
| 17 | 5.7B USD | 90 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score